HeraMED (ASX:HMD) has raised US$2.8 million via placement and SPP
HeraMED Limited (ASX:HMD) has raised funds to accelerate HearCARE’s commercial roll out and progress ongoing research projects.
HeraMED is a medical technology company leading the digital transformation of maternity care with its proprietary telehealth platform. The company offers a platform that utilizes hardware and software to reshape the doctor/patient relationship using its clinically validated in-home fetal and maternal heart rate monitor, HeraBEAT, cloud computing, artificial intelligence, big data and a digital social networking dashboard.
Oaklins’ team in Australia acted as lead manager in this transaction.
Talk to the deal team
Related deals
Forza Doors has secured new debt facilities
Forza Doors Ltd. has secured new senior debt facilities from Triple Point. The new debt facilities will be used to refinance the business and support its future growth.
Learn moreSun European Partners has secured financing to support its acquisition of B&H Worldwide
Sun European Partners has raised debt facilities to support its acquisition of B&H Worldwide.
Learn moreSkynamo has been acquired by Klipboard
Klipboard, a global provider of vertical business management software, has completed the acquisition of Skynamo, a market-leading mobile field sales platform used by manufacturers, wholesalers and distributors worldwide. The acquisition adds Skynamo’s award-winning field sales platform to Klipboard’s portfolio and enhances its ability to support wholesalers, distributors and retailers in managing complex operations across many industries.
Learn more